Prevention of allergy by a recombinant multi-allergen vaccine with reduced IgE binding and preserved T cell epitopes

European Journal of Immunology

Volumn 35, Issue 11, 2005, Pages 3268-3276

  Karamloo, Fariba ^a,f   Schmid Grendelmeier, Peter ^a,b,f   Kussebi, Fatimah ^a,f   Akdis, Mübeccel ^a,f   Salagianni, Maria ^c,f   von Beust, Barbara R ^b,f   Reimers, Andrea ^d,f   Zumkehr, Judith ^a,f   Soldatova, Lyudmilla ^e,f   Housley Markovic, Zora ^e,f   Müller, Ulrich ^d,f   Kündig, Thomas ^b,f   Kemeny, David M ^c,f   Spangfort, Michael D ^f,g   Blaser, Kurt ^a,f   Akdis, Cezmi A ^a,f  

^a SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d Spital Ziegler   (Switzerland)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^f UNIVERSITY OF BASEL   (Switzerland)

^g ALK ABELLÓ   (Denmark)

Author keywords

Allergy; Antibodies; Antigens peptides epitopes; T cells; Vaccination

Indexed keywords

ALLERGEN; AMINO ACID; BEE VENOM; EPITOPE; HYALURONIDASE; IMMUNOGLOBULIN E; MELITTIN; PHOSPHOLIPASE A2; RECOMBINANT VACCINE;

ALLERGY; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BASOPHIL; CONTROLLED STUDY; CROSS LINKING; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; MAST CELL; MOUSE; NONHUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTECTION; T LYMPHOCYTE;

ALLERGENS; ANIMALS; BEES; BINDING SITES, ANTIBODY; CELLS, CULTURED; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; HYALURONOGLUCOSAMINIDASE; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INSECT BITES AND STINGS; MICE; MICE, INBRED C57BL; PHOSPHOLIPASES A; T-LYMPHOCYTES; VACCINES, SYNTHETIC;

EID: 27944467811     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425522     Document Type: Article

References (39)

1. Hopkin, J. M., Mechanisms of enhanced prevalence of asthma and atopy in developed countries. Curr. Opin. Immunol. 1997. 9: 788-792.
2. Akdis, C. A., Blesken, T., Wymann, D., Akdis, M. and Blaser, K., Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants. Eur. J. Immunol. 1998. 28: 914-925.
3. 2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J. Clin. Invest. 1996. 98: 1676-1683.
4. 2 from honey bee venom is similar. J. Allergy Clin. Immunol. 1995. 96: 395-402.
5. Soldatova, L. N., Crameri, R., Gmachl, M., Kemeny, D. M., Schmidt, M., Weber, M. and Mueller, U. R., Superior biologic activity of the recombinant bee venom allergen hyaluronidase expressed in baculovirus-infected insect cells as compared with Escherichia coli. J. Allergy Clin. Immunol. 1998. 101: 691-698.
6. Paull, B. R., Yunginger, J. W. and Gleich, G. J., Melittin: an allergen of honeybee venom. J. Allergy Clin. Immunol. 1977. 59: 334-338.
7. Nish, W. A., Charlesworth, E. N., Davis, T. L., Whisman, B. A., Valtier, S., Charlesworth, M. G. and Lieferman, K. M., The effect of immunotherapy on the cutaneous late phase response to antigen. J. Allergy Clin. Immunol. 1994. 93: 484-493.
8. Bentley, A. M., Jacobson, M. R., Cumberworth, V., Barkans, J. R., Moqbel, R. and Schwartz, L. B., Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells. J. Allergy Clin. Immunol. 1992. 89: 877-883.
9. Akdis, C. A. and Blaser, K., Bypassing IgE and targeting T cells for specific immunotherapy of allergy. Trends Immunol. 2001. 22: 175-178.
10. Van der Heijden, F. L., van Neerven, R. J. J., van Katwijk, M., Bos, J. D. and Kapsenberg, M. L., Serum IgE-facilitated allergen presentation in allergic disease. J. Immunol. 1993. 150: 3643-3647.
11. Waldmann, T. A., Immunotherapy: Past, present and future. Nat. Med. 2003. 9: 269-277.
12. 2. Structural and functional analysis of human IgG4 antibodies reveals potential role in protection. J. Immunol. 1994. 152: 5514-5522.
13. Moverare, R., Elfman, L., Vesterinen, E., Metso, T. and Haahtela, T., Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System. Allergy 2002. 57: 423-430.
14. 2 in a complex with a transition-state analogue. Science 1990. 250: 1563-1566.
15. Owen, M. D. and Pfaff, L. A., Melittin synthesis in the venom system of the honey bee (Apis mellifera L.). Toxicon 1995. 33: 1181-1188.
16. Werkmeister, J. A., Kirkpatrick, A., McKenzie, J. A. and Rivett, D. E., The effect of sequence variations and structure on the cytolytic activity of melittin peptides. Biochim. Biophys. Acta 1993. 1157: 50-54.
17. 2. J. Immunol. 1993. 150: 3582-3591.
18. lck and ZAP-70 tyrosine kinase activities. J. Immunol. 1997. 159: 53-60.
19. Akdis, C. A., Blesken, T., Akdis, M., Wüthrich, B. and Blaser, K., Role of IL-10 in specific immunotherapy. J. Clin. Invest. 1998. 102: 98-106.
20. Larche, M. and Wraith, D. C., Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat. Med. 2005. 11: S69-S76.
21. Akdis, M., Verhagen, J., Taylor, A., Karamloo, F., Karagiannidis, C., Crameri, R., Thunberg, S., et al., Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. 2004. 199: 1567-1575.
22. 2 induces specific T cell anergy in bee sting allergic patients. J. Allergy Clin. Immunol. 1998. 101: 747-754.
23. Woodfolk, J. A., Sung, S. S., Benjamin, D. C., Lee, J. K. and Platts-Mills, T. A., Distinct human T cell repertoires mediate immediate and delayed-type hypersensitivity to the Trichophyton antigen, Tri r 2. J. Immunol. 2000. 165: 4379-4387.
24. Vrtala, S., Akdis, C. A., Budak, F., Akdis, M., Blaser, K., Kraft, D. and Valenta, R., T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies. J. Immunol. 2000. 165: 6653-6659.
25. Linhart, B., Jahn-Schmid, B., Verdino, P., Keller, W., Ebner, C., Kraft, D. and Valenta, R., Combination vaccines for the treatment of grass pollen allergy consisting of genetically engineered hybrid molecules with increased immunogenicity. FASEB J. 2002. 16: 1301-1303.
26. Niederberger, V., Horak, F., Vrtala, S., Spitzauer, S., Krauth, M. T., Valent, P., Reisinger, J., et al., Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc. Natl. Acad. Sci. USA 2004. 101 Suppl. 2: 14677-14682.
27. Laver, W. G., Air, G. M., Webster, R. G. and Smith-Gill, S. J., Epitopes on protein antigens: misconceptions and realities. Cell 1990. 61: 553-556.
28. Jutel, M., Watanabe, T., Klunker, S., Akdis, M., Thomet, O. A., Malolepszy, J., Zak-Nejmark, T., et al., Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 2001. 413: 420-425.
29. Coyle, A. J., Wagner, K., Bertrand, C., Tsuyuki, S., Bews, J. and Heusser, C., Central role of immunoglobulin-E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: Inhibition by a non-anaphylactogenic anti-IgE antibody. J. Exp. Med. 1996. 183: 1303-1308.
30. Akdis, C. A., Kussebi, F., Pulendran, B., Akdis, M., Lauener, R. P., Schmidt-Weber, C. B., Klunker, S., et al., Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides. Eur. J. Immunol. 2003. 33: 2717-2726.
31. de Heer, H. J., Hammad, H., Soullie, T., Hijdra, D., Vos, N., Willart, M. A., Hoogsteden, H. C. and Lambrecht, B. N., Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 2004. 200: 89-98.
32. Markovic-Housley, Z., Miglierini, G., Soldatova, L., Rizkallah, P. J., Muller, U. and Schirmer, T., Crystal structure of hyaluronidase, a major allergen of bee venom. Structure Fold. Des. 2000. 8: 1025-1035.
33. Moser, M., Crameri, R., Menz, G., Schneider, T., Dudler, T., Virchow, C., Gmachl, M., et al., Cloning and expression of recombinant Aspergillus fumigatus allergen I/a (rAsp f I/a) with IgE binding and type I skin test activity. J. Immunol. 1992. 149: 454-460.
34. Hemmann, S., Blaser, K. and Crameri, R., Allergens of Aspergillus fumigatus and Candida boidinii share IgE-binding epitopes. Am. J. Respir. Crit. Care Med. 1997. 156: 1956-1962.
35. Karamloo, F., Wangorsch, A., Kasahara, H., Davin, L. B., Haustein, D., Lewis, N. G. and Vieths, S., Phenylcoumaran benzylic ether and isoflavonoid reductases are a new class of cross-reactive allergens in birch pollen, fruits and vegetables. Eur. J. Biochem. 2001. 268: 5310-5320.
36. Cahen, Y. D., Maly, F. E. and Wuthrich, B., Cellular antigen stimulation test (CAST)-applicability in the diagnosis of insect toxin allergies. Schweiz. Med. Wochenschr. 1997. 127: 5-11.
37. Demoly, P., Bousquet, J., Manderscheid, J. C., Dreborg, S., Dhivert, H. and Michel, F. B., Precision of skin prick and puncture tests with nine methods. J. Allergy Clin. Immunol. 1991. 88: 758-762.
38. Thomas, M. J., Noble, A., Sawicka, E., Askenase, P. W. and Kemeny, D. M., CD8 T cells inhibit IgE via dendritic cell IL-12 induction that promotes Th1 T cell counter-regulation. J. Immunol. 2002. 168: 216-223.
39. Herrick, C. A., MacLeod, H., Glusac, E., Tigelaar, R. E. and Bottomly, K., Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4. J. Clin. Invest. 2000. 105: 765-775.